Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Viragen’s Multiferon approved for sale in Chile
Multiferon is now approved in Chile for the second-line treatment of any and all diseases in which recombinant interferon therapy failed, possibly due to the formation of neutralizing
Multiferon is now approved in Chile for the second-line treatment of any and all diseases in which recombinant interferon therapy failed, possibly due to the formation of neutralizing
Saber-Bupivacaine is based on Durect’s patented Saber delivery technology and is intended to be administered around the surgical site after surgery to provide three days or more of
Under the agreement, Cerner will provide its Millennium software suite as part of a project to develop a fully operational electronic medical record (EMR) system, with the first
Based on the FDA’s assessment of currently data and the availability of other treatment options in the US that do prolong life, AstraZeneca said that it would revise
The NIH will offer the money as part of grant awards to nine institutions over a three year period. According to Dr Thomas Insel, director of the National
Medcon said its technology offers diagnostic digital image management and archiving, procedure reporting and workflow management. McKesson hopes the addition of these products will further strengthen its presence
Provid will employ its expertise in structure-based design, peptide mimetics technology, and medicinal chemistry to develop the lead compounds. “We are pleased to be complementing the biology of
Data from the clinical trials will then be used as part of Merck’s FDA application for Arcoxia. The FDA issued Arcoxia with an “approvable” in October last year,
The two-part, open-label, dose escalation phase I clinical study is designed to evaluate VX-680 when administered over a five-day treatment cycle in patients with hematologic cancers. The study
LiquiColl is a liquefied collagen gel developed for tissue engineering and localized delivery of therapeutic agents. It is comprised of native fibrillar collagen dispersed and stabilized in buffered